KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Asset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Guardant Health (GH) Cash from Investing Activities (2017 - 2025)

Historic Cash from Investing Activities for Guardant Health (GH) over the last 9 years, with Q3 2025 value amounting to -$14.4 million.

  • Guardant Health's Cash from Investing Activities rose 9513.27% to -$14.4 million in Q3 2025 from the same period last year, while for Sep 2025 it was $288.4 million, marking a year-over-year decrease of 2635.77%. This contributed to the annual value of -$261.3 million for FY2024, which is 13109.88% down from last year.
  • As of Q3 2025, Guardant Health's Cash from Investing Activities stood at -$14.4 million, which was up 9513.27% from -$10.6 million recorded in Q2 2025.
  • Over the past 5 years, Guardant Health's Cash from Investing Activities peaked at $663.5 million during Q4 2023, and registered a low of -$294.8 million during Q3 2024.
  • Its 5-year average for Cash from Investing Activities is $49.7 million, with a median of $28.1 million in 2024.
  • Per our database at Business Quant, Guardant Health's Cash from Investing Activities crashed by 23079.58% in 2023 and then soared by 97911.35% in 2025.
  • Quarter analysis of 5 years shows Guardant Health's Cash from Investing Activities stood at -$266.7 million in 2021, then soared by 126.48% to $70.6 million in 2022, then surged by 839.38% to $663.5 million in 2023, then crashed by 98.41% to $10.5 million in 2024, then plummeted by 236.28% to -$14.4 million in 2025.
  • Its last three reported values are -$14.4 million in Q3 2025, -$10.6 million for Q2 2025, and $302.9 million during Q1 2025.